International Clinical Trial: An Open-label, Single-arm, Exploratory Clinical Study to Evaluate the Efficacy and Safety of mecapegfilgrastim in Preventing Chemotherapy-Induced Neutropenia in Patients with Breast Cancer

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116027) titled 'An Open-label, Single-arm, Exploratory Clinical Study to Evaluate the Efficacy and Safety of mecapegfilgrastim in Preventing Chemotherapy-Induced Neutropenia in Patients with Breast Cancer' on Jan. 4.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Beijing Cancer Hospital

Condition: Breast Cancer

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-01-15

Target Sample Size: Experimental Group:48;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=299962

Published by HT Digital Content Services with permi...